The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-{3-[4-(4-Methyl-benzyl)-piperidin-1-yl]-prop-1-ynyl}-1,3-dihydro-benzoimidazol-2-one ID: ALA419399
PubChem CID: 10689828
Max Phase: Preclinical
Molecular Formula: C23H25N3O
Molecular Weight: 359.47
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ccc(CC2CCN(CC#Cc3ccc4[nH]c(O)nc4c3)CC2)cc1
Standard InChI: InChI=1S/C23H25N3O/c1-17-4-6-19(7-5-17)15-20-10-13-26(14-11-20)12-2-3-18-8-9-21-22(16-18)25-23(27)24-21/h4-9,16,20H,10-15H2,1H3,(H2,24,25,27)
Standard InChI Key: LHUVDZHUMLCYFE-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
11.4417 -2.2417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8417 -1.6667 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.0792 -2.9792 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.1125 -2.0625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2625 -2.8750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1417 -1.7292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9250 -2.0167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7250 -1.9750 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.2667 -2.2417 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.3417 -1.7792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7042 -2.3042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6250 -3.4042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3542 -1.4417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9542 -1.6792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8625 -2.7792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0250 -3.2500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8000 -3.5417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8500 -3.1250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4625 -2.6625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4500 -3.0167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3792 -3.7750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8917 -2.4292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6042 -3.4792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1167 -2.1292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3125 -2.2042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2250 -3.3042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6875 -2.3667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 1 1 0
4 2 1 0
5 3 1 0
6 7 3 0
7 11 1 0
8 13 1 0
9 1 1 0
10 4 2 0
11 10 1 0
12 5 2 0
13 6 1 0
14 8 1 0
15 8 1 0
16 17 1 0
17 20 1 0
18 12 1 0
19 24 2 0
20 26 1 0
21 16 1 0
22 16 2 0
23 21 2 0
24 22 1 0
25 14 1 0
26 15 1 0
27 19 1 0
5 4 1 0
11 18 2 0
25 20 1 0
19 23 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 359.47Molecular Weight (Monoisotopic): 359.1998AlogP: 3.88#Rotatable Bonds: 3Polar Surface Area: 52.15Molecular Species: NEUTRALHBA: 3HBD: 2#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.47CX Basic pKa: 8.02CX LogP: 5.12CX LogD: 4.56Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.70Np Likeness Score: -0.88
References 1. Wright JL, Gregory TF, Kesten SR, Boxer PA, Serpa KA, Meltzer LT, Wise LD, Espitia SA, Konkoy CS, Whittemore ER, Woodward RM.. (2000) Subtype-selective N-methyl-D-aspartate receptor antagonists: synthesis and biological evaluation of 1-(heteroarylalkynyl)-4-benzylpiperidines., 43 (18): [PMID:10978188 ] [10.1021/jm000023o ]